The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
HIV-1 establishes infection in astrocytes and macroage-lineage cells of the central nervous system (CNS). Certain antiretroviral drugs (ARVs) can penetrate the CNS, and are therefore often used in neurologically active combined antiretroviral therapy (Neuro-cART) regimens, but their relative activit...
Guardado en:
Autores principales: | Lachlan R Gray, Gilda Tachedjian, Anne M Ellett, Michael J Roche, Wan-Jung Cheng, Gilles J Guillemin, Bruce J Brew, Stuart G Turville, Steve L Wesselingh, Paul R Gorry, Melissa J Churchill |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d97c6377d27544618061aac3fbdc631d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
por: Thong Phe, et al.
Publicado: (2013) -
Characterisation of the expression of NMDA receptors in human astrocytes.
por: Ming-Chak Lee, et al.
Publicado: (2010) -
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
por: Y. A. Gonchikova, et al.
Publicado: (2017) -
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
por: Jayakrishna Ambati, et al.
Publicado: (2020) -
Astrocytes integrate and drive action potential firing in inhibitory subnetworks
por: Tara Deemyad, et al.
Publicado: (2018)